Soulmates Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
Antiverse develops therapeutic antibodies designed using machine learning and built in its own laboratories. It generates and tests antibody candidates against difficult disease targets, including membrane proteins, for pharmaceutical and foundation partners.
Rightcharge secures £1.6m seed round led by Soulmates Ventures to simplify EV charging data for Europe's fleets
Rightcharge provides a payments platform for electric vehicle fleets that automates home charging reimbursements and consolidates public charging costs, linking directly to energy accounts to reduce admin, errors and charging expenses for businesses.
Signapse closes £2m seed round to accelerate accessibility for deaf people
Signapse builds generative AI software that translates written and spoken English into sign language, improving accessibility by enabling scalable, video-based communication for Deaf users across digital and physical environments.
More venture news
- 1 Jul 2026
10011001 raises £22m Series A led by Lux Capital to build AI system for critical infrastructure operators
Series AEnterprise - 2 Jul 2026
StirlingXStirlingX lands £15m Series A led by Ventura Capital and Rokos Capital Management to build sovereign data intelligence platform for critical infra
Series ADefence - 29 Jun 2026
GaussionGaussion raises £21m led by BGF and AlbionVC to enable rapid battery pack charging with external magnetic field
Series ADeep Tech
